BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4963959)

  • 1. [On the tuberculostatic effect of some new isonicotinoylhydrazide derivatives].
    Gheorghiu P; Stroescu V; Demetrescu C; Benes H; Gane P; Steflea D; Moldoveanu O
    Pharmazie; 1966 Feb; 21(2):115-6. PubMed ID: 4963959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of saturation of Mycobacterium tuberculosis--a theoretical basis of the method of mazimum concentration of tuberculostatic preparations].
    Bondarev IM
    Probl Tuberk; 1974; 52(6):58-64. PubMed ID: 4211415
    [No Abstract]   [Full Text] [Related]  

  • 3. [The tuberculostatic test].
    Rudoĭ NM
    Lab Delo; 1966; 7():427-31. PubMed ID: 4170791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the antitubercular activity of new derivatives of aromatic hydrazides. IX. Antitubercular activity in vitro of several new substituted isonicotinoylhydrazides, diphenylsulfonylhydrazides and diphenylsulfonylhydrazidones].
    Teitel A; Stroescu V; Demetrescu C; Beneş H; Chiriţă C; Gane P; Steflea D; Chiculescu O
    Fiziol Norm Patol; 1967; 13(6):551-60. PubMed ID: 4969837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
    Shkurupií VA; Kurunov IN; Arkhipov SA
    Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence, not resistance, is the cause of loss of isoniazid effect.
    Wallis RS; Palaci M; Eisenach K
    J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 15. [Connection between chemical constitution and antimicrobial activity. 18. Orientating studies of the tuberculostatic properties of some dithiocarbamic acid esters (dithiourethanes) and dithiocarbamic salts].
    Weuffen W; Kewitsch A
    Arch Exp Veterinarmed; 1967; 21(4):1049-59. PubMed ID: 4970713
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of resistance to isoniazid in clinical isolates of Mycobacterium tuberculosis by molecular techniques.
    Sharma M; Altamirano M; Prasad HK; Myneedo VP; Nand N
    J Assoc Physicians India; 2001 Jul; 49():772-3. PubMed ID: 11573575
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of early bactericidal activity: new insights into isoniazid pharmacokinetics.
    Gillespie SH
    Clin Infect Dis; 2004 Nov; 39(10):1431-2. PubMed ID: 15546076
    [No Abstract]   [Full Text] [Related]  

  • 18. [An experimental study on the antituberculous activity of rifampicin].
    Toyoara M
    Kekkaku; 1971 Jun; 46(6):211-6. PubMed ID: 4997827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the sensitivity of a rapidly growing Mycobacterium strain H-7, to antitubercular drugs].
    Ishiguro S
    Kekkaku; 1967 Oct; 42(10):413-6. PubMed ID: 4966679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.